Advertisement

Advertisement

Departments

Advertisement

Advertisement



Jun
18
Today In Oncology
Serum MicroRNAs for the Diagnosis of Pancreatic and Biliary Tract Cancers
TONIC: PD-1 Blockade in Metastatic Triple-Negative Breast Cancer
U.S. Cancer Survivors Numbered Nearly 17 Million at the Start of 2019
KEYNOTE-001: 5-Year Overall Survival With Pembrolizumab in Advanced NSCLC
Toxicity With Prostate-Only vs Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy
View More 
;
Advertisement
Most Read Stories
Resuming Immune Checkpoint Inhibitor Therapy After Immune-Mediated Diarrhea and Colitis
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
FDA Approves Pembrolizumab for the First-Line Treatment of Head and Neck Squamous Cell Carcinoma
2019 ASCO: CLL14 Trial Evaluates First-Line Venetoclax/Obinutuzumab in Previously Untreated CLL
MONALEESA-7 Shows Overall Survival Benefit for Ribociclib/Endocrine Therapy
View More 
Most Viewed Videos
Sara A. Hurvitz, MD, on HER2-Positive Breast Cancer: KRISTINE Trial on Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy
Richard T. Penson, MD, and Don S. Dizon, MD, on Ovarian Cancer: SOLO3 Trial on Olaparib vs Chemotherapy in Relapsed Disease
Paul G. Richardson, MD, on Relapsed or Refractory Multiple Myeloma: Adding Isatuximab to Pomalidomide and Low-Dose Dexamethasone
Michael J. Morris, MD, on Metastatic Prostate Cancer: Adding Abiraterone Acetate to Enzalutamide
Hope S. Rugo, MD, and Matteo Lambertini, MD, PhD, on the SOPHIA Trial in HER2-Positive Metastatic Breast Cancer: Chemotherapy Plus Margetuximab vs Trastuzumab
View More 
© 2019 HSP News Service, L.L.C.